1,904 controls | All prostate cancers | Non-aggressive prostate cancersb | Aggressive prostate cancersc | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1,904 cases and 1,962 controls | 1,384 cases and 1,962 controls | 512 cases and 1,962 controls | |||||||||
Sunlight exposure index | n | (%) | n | (%) | OR (95% CI)a | n | (%) | OR (95% CI)a | n | (%) | OR (95% CI)a |
CEvents d | |||||||||||
None | 52 | (2.7) | 55 | (2.9) | 1.32 (0.82-2.14) | 35 | (2.5) | 1.29 (0.76-2.20) | 19 | (3.7) | 1.53 (0.79-2.87) |
Q1 | 478 | (24.4) | 506 | (26.6) | 1.11 (0.90-1.37) | 377 | (27.2) | 1.12 (0.89-1.41) | 128 | (25.0) | 1.09 (0.79-1.50) |
Q2 | 477 | (24.3) | 438 | (23.0) | 0.91 (0.74-1.11) | 332 | (24.0) | 0.94 (0.75-1.17) | 105 | (20.5) | 0.84 (0.61-1.14) |
Q3 | 477 | (24.3) | 474 | (24.9) | 1.00 (0.82-1.22) | 324 | (23.4) | 0.92 (0.73-1.15) | 146 | (28.5) | 1.19 (0.89-1.59) |
Q4 | 478 | (24.4) | 431 | (22.6) | 1.00 (reference) | 316 | (22.8) | 1.00 (reference) | 114 | (22.3) | 1.00 (reference) |
p-trend = 0.56 | p-trend = 0.57 | p-trend = 0.58 | |||||||||
CDuration e | |||||||||||
None | 52 | (2.7) | 55 | (2.9) | 1.38 (0.86-2.23) | 35 | (2.5) | 1.41 (0.83-2.41) | 19 | (3.7) | 1.41 (0.73-2.65) |
Q1 | 478 | (24.4) | 483 | (25.4) | 1.10 (0.89-1.37) | 363 | (26.2) | 1.18 (0.93-1.49) | 118 | (23.0) | 0.92 (0.67-1.26) |
Q2 | 477 | (24.3) | 467 | (24.5) | 0.99 (0.81-1.22) | 333 | (24.1) | 1.00 (0.79-1.25) | 134 | (26.2) | 0.99 (0.73-1.33) |
Q3 | 476 | (24.3) | 489 | (25.7) | 1.13 (0.92-1.39) | 366 | (26.4) | 1.20 (0.96-1.50) | 119 | (23.2) | 0.95 (0.70-1.28) |
Q4 | 479 | (24.4) | 410 | (21.5) | 1.00 (reference) | 287 | (20.7) | 1.00 (reference) | 122 | (23.8) | 1.00 (reference) |
p-trend = 0.38 | p-trend = 0.30 | p-trend = 0.66 |